NC

Nexthera Capital Portfolio holdings

AUM $120M
1-Year Est. Return 20.18%
This Quarter Est. Return
1 Year Est. Return
+20.18%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$120M
AUM Growth
+$37.7M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
35
New
Increased
Reduced
Closed

Top Buys

1
+$11.2M
2
+$6.99M
3
+$6.94M
4
PCRX icon
Pacira BioSciences
PCRX
+$6.48M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$5.77M

Top Sells

1
+$9.5M
2
+$5.08M
3
+$4.18M
4
NVS icon
Novartis
NVS
+$3.83M
5
CBAY
Cymabay Therapeutics
CBAY
+$2.79M

Sector Composition

1 Healthcare 92.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EXEL icon
26
Exelixis
EXEL
$11.9B
– –
-90,356
HRTX icon
27
Heron Therapeutics
HRTX
$238M
– –
-388,623
KNSA icon
28
Kiniksa Pharmaceuticals
KNSA
$3.11B
– –
-67,692
NVS icon
29
Novartis
NVS
$254B
– –
-50,587
SAGE
30
DELISTED
Sage Therapeutics
SAGE
– –
-6,200
DCPH
31
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
– –
-42,865
CBAY
32
DELISTED
Cymabay Therapeutics
CBAY
– –
-210,257
ACOR
33
DELISTED
Acorda Therapeutics
ACOR
– –
-1,290
CHMA
34
DELISTED
Chiasma, Inc. Common Stock
CHMA
– –
-203,948
STML
35
DELISTED
Stemline Therapeutics, Inc.
STML
– –
-325,526
1
2